Position in NVS
as of Jun 30, 2026
· filed Jul 8, 2026
Position Value
$510,907
+$5,458 QoQ
Shares Held
3,260
-1.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#879
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 81%
Shared 0%
None 19%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BEACON INVESTMENT ADVISORY SERVICES, INC. holds $137,808,603 across 14 Drug Manufacturers - General names. NVS ranks #11 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
|
104,988 | $38,018,254 | |
| 2 | JNJ |
Johnson & Johnson
|
112,400 | $28,546,228 | |
| 3 | ABBV |
AbbVie Inc.
|
84,475 | $21,257,289 | |
| 4 | LLY |
ELI LILLY & Co
|
17,158 | $20,579,821 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
112,362 | $14,195,815 | |
| 6 | NVO |
Novo Nordisk A S
|
145,810 | $6,990,131 | |
| 7 | MRK |
Merck & Co., Inc.
|
25,298 | $3,250,793 | |
| 8 | BIIB |
Biogen Inc.
|
12,229 | $2,642,197 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $510,907 | 3,260 | Shares | Sole | 2026-07-08 | |
| 2026-03-31 | $505,449 | 3,309 | Shares | Sole | 2026-04-14 | |
| 2025-12-31 | $682,456 | 4,950 | Shares | Sole | 2026-01-16 | |
| 2025-09-30 | $645,688 | 5,035 | Shares | Sole | 2025-10-16 | |
| 2025-06-30 | $613,157 | 5,067 | Shares | Sole | 2025-07-15 | |
| 2025-03-31 | $568,882 | 5,103 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $700,340 | 7,197 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $889,564 | 7,734 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $856,577 | 8,046 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $851,997 | 8,808 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $1,002,632 | 9,930 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $1,035,814 | 10,169 | Shares | Sole | 2023-10-31 | |
| 2023-06-30 | $1,032,208 | 10,229 | Shares | Sole | 2023-07-21 | |
| 2023-03-31 | $883,752 | 9,606 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $847,415 | 9,341 | Shares | Sole | 2023-01-13 | |
| 2022-09-30 | $745,506 | 9,808 | Shares | Sole | 2022-10-20 | |
| 2022-06-30 | $829,323 | 9,811 | Shares | Sole | 2022-07-21 | |
| 2022-03-31 | $822,129 | 9,369 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $792,478 | 9,060 | Shares | Sole | 2022-02-04 | |
| 2021-09-30 | $745,424 | 9,115 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $1,155,463 | 12,664 | Shares | Sole | 2021-08-02 | |
| 2021-03-31 | $4,050,555 | 47,386 | Shares | Sole | 2021-05-21 | |
| 2020-12-31 | $4,349,162 | 46,057 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $4,212,429 | 48,441 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $4,129,522 | 47,281 | Shares | Sole | 2020-07-28 | |
| 2020-03-31 | $3,751,145 | 45,496 | Shares | Sole | 2020-05-05 | |
| No filing history on record for this holder in this stock. | ||||||